 GLP-1 is an agent for treatment of type 2 diabetes and may have protective effects on the cardiovascular system. The mechanism is complex and there seems to be a dual function with intact GLP-1 7-36, acting through the GLP-1 receptor, and the GLP-1 9-36 metabolite acting independently of the GLP-1 receptor. 